A Cross-Sectional Study on the Relationship Between Rosacea Severity and Quality of Life or Psychological State

References

• Schaller M, Almeida LMC, Bewley A, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol. 2020;182(5):1269–1276. doi:10.1111/bjd.18420
   PubMed Web of Science ®Google Scholar
• Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78(1):148–155. doi:10.1016/j.jaad.2017.08.037
   PubMed Web of Science ®Google Scholar
• van Zuuren EJ, Solomon CG. Rosacea. N Engl J Med. 2017;377(18):1754–1764. doi:10.1056/NEJMcp1506630
   PubMed Web of Science ®Google Scholar
• Alexis AF, Callender VD, Baldwin HE, Desai SR, Rendon MI, Taylor SC. Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: review and clinical practice experience. J Am Acad Dermatol. 2019;80(6):1722–9 e7. doi:10.1016/j.jaad.2018.08.049
   PubMed Web of Science ®Google Scholar
• Tan J, Schofer H, Araviiskaia E, et al. Prevalence of rosacea in the general population of Germany and Russia - The RISE study. J Eur Acad Dermatol Venereol. 2016;30(3):428–434. doi:10.1111/jdv.13556
   PubMed Web of Science ®Google Scholar
• Rueda LJ, Motta A, Pabon JG, et al. Epidemiology of rosacea in Colombia. Int J Dermatol. 2017;56(5):510–513. doi:10.1111/ijd.13491
   PubMed Web of Science ®Google Scholar
• Gether L, Overgaard LK, Egeberg A, Thyssen JP. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol. 2018;179(2):282–289. doi:10.1111/bjd.16481
   PubMed Web of Science ®Google Scholar
• Li J, Wang B, Deng Y, et al. Epidemiological features of rosacea in Changsha, China: a population-based, cross-sectional study. J Dermatol. 2020;47(5):497–502. doi:10.1111/1346-8138.15301
   PubMed Web of Science ®Google Scholar
• Rainer BM, Kang S, Chien AL. Rosacea: epidemiology, pathogenesis, and treatment. Dermatoendocrinol. 2017;9(1):e1361574. doi:10.1080/19381980.2017.1361574
   PubMed Web of Science ®Google Scholar
• Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol. 2013;69(6 Suppl 1):S15–S26. doi:10.1016/j.jaad.2013.04.045
   PubMed Web of Science ®Google Scholar
• Woo YR, Han YJ, Kim HS, Cho SH, Lee JD. Updates on the risk of neuropsychiatric and gastrointestinal comorbidities in rosacea and its possible relationship with the Gut-Brain-Skin Axis. Int J Mol Sci. 2020;21:22. doi:10.3390/ijms21228427
   Web of Science ®Google Scholar
• Parkins GJ, Maan A, Dawn G. Neurogenic rosacea: an uncommon and poorly recognized entity? Clin Exp Dermatol. 2015;40(8):930–931. doi:10.1111/ced.12630
   PubMed Web of Science ®Google Scholar
• van Zuuren EJ, Arents BWM, van der Linden MMD, Vermeulen S, Fedorowicz Z, Tan J. Rosacea: new concepts in classification and treatment. Am J Clin Dermatol. 2021;22(4):457–465. doi:10.1007/s40257-021-00595-7
   PubMed Web of Science ®Google Scholar
• Thiboutot D, Anderson R, Cook-Bolden F, et al. Standard management options for rosacea: the 2019 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2020;82(6):1501–1510. doi:10.1016/j.jaad.2020.01.077
   PubMed Web of Science ®Google Scholar
• Rainer BM, Fischer AH, Luz Felipe da Silva D, Kang S, Chien AL. Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: results of a case-control study. J Am Acad Dermatol. 2015;73(4):604–608. doi:10.1016/j.jaad.2015.07.009
   PubMed Web of Science ®Google Scholar
• Little AC, Jones BC, DeBruine LM. Facial attractiveness: evolutionary based research. Philos Trans R Soc Lond B Biol Sci. 2011;366(1571):1638–1659. doi:10.1098/rstb.2010.0404
   PubMed Web of Science ®Google Scholar
• Johnston VS. Mate choice decisions: the role of facial beauty. Trends Cogn Sci. 2006;10(1):9–13. doi:10.1016/j.tics.2005.11.003
   PubMed Web of Science ®Google Scholar
• Zebrowitz LA, Montepare JM. Social psychological face perception: why appearance matters. Soc Personal Psychol Compass. 2008;2(3):1497. doi:10.1111/j.1751-9004.2008.00109.x
   PubMedGoogle Scholar
• Halioua B, Cribier B, Frey M, Tan J. Feelings of stigmatization in patients with rosacea. J Eur Acad Dermatol Venereol. 2017;31(1):163–168. doi:10.1111/jdv.13748
   PubMed Web of Science ®Google Scholar
• Oussedik E, Bourcier M, Tan J. Psychosocial burden and other impacts of rosacea on patients’ quality of life. Dermatol Clin. 2018;36(2):103–113. doi:10.1016/j.det.2017.11.005
   PubMed Web of Science ®Google Scholar
• Bewley A, Fowler J, Schofer H, Kerrouche N, Rives V. Erythema of rosacea impairs health-related quality of life: results of a meta-analysis. Dermatol Ther. 2016;6(2):237–247. doi:10.1007/s13555-016-0106-9
   Web of Science ®Google Scholar
• Huang Y, Yan S, Xie H, et al. Health related quality of life of rosacea patients in china assessed by dermatology life quality index and willingness to pay. Patient Prefer Adherence. 2022;16:659–670. doi:10.2147/PPA.S345258
   PubMed Web of Science ®Google Scholar
• Moustafa F, Lewallen RS, Feldman SR. The psychological impact of rosacea and the influence of current management options. J Am Acad Dermatol. 2014;71(5):973–980. doi:10.1016/j.jaad.2014.05.036
   PubMed Web of Science ®Google Scholar
• Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Patients with rosacea have increased risk of depression and anxiety disorders: a Danish Nationwide Cohort Study. Dermatology. 2016;232(2):208–213. doi:10.1159/000444082
   PubMed Web of Science ®Google Scholar
• Tan J, Liu H, Leyden JJ, Leoni MJ. Reliability of Clinician Erythema Assessment grading scale. J Am Acad Dermatol. 2014;71(4):760–763. doi:10.1016/j.jaad.2014.05.044
   PubMed Web of Science ®Google Scholar
• Seo JK, Shin EJ, Jeong KH, Shin MK. Clinician severity assessment grading scale on erythematotelangiectatic rosacea. Indian J Dermatol. 2021;66(2):203–205. doi:10.4103/ijd.IJD_611_19
   PubMed Web of Science ®Google Scholar
• Zhao S, Wang M, Zhou Y, Yan Y. The therapeutic effects in patients with rosacea: how do we evaluate them? J Cosmet Dermatol. 2022;21(2):506–512. doi:10.1111/jocd.14713
   PubMed Web of Science ®Google Scholar
• Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol. 2005;125(4):659–664. doi:10.1111/j.0022-202X.2005.23621.x
   PubMed Web of Science ®Google Scholar
• Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216. doi:10.1111/j.1365-2230.1994.tb01167.x
   PubMed Web of Science ®Google Scholar
• Nicholson K, Abramova L, Chren MM, Yeung J, Chon SY, Chen SC. A pilot quality-of-life instrument for acne rosacea. J Am Acad Dermatol. 2007;57(2):213–221. doi:10.1016/j.jaad.2007.01.048
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
   PubMed Web of Science ®Google Scholar
• Cassiani-Miranda CA, Scoppetta O, Cabanzo-Arenas DF. Validity of the Hospital Anxiety and Depression Scale (Hads) in primary care patients in Colombia. Gen Hosp Psychiatry. 2022;74:102–109. doi:10.1016/j.genhosppsych.2021.01.014
   PubMed Web of Science ®Google Scholar
• Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (Hads-A). Arthritis Care Res. 2011;63(Suppl 11):S467–S472. doi:10.1002/acr.20561
   PubMed Web of Science ®Google Scholar
• The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551–558. doi:10.1017/S0033291798006667
   PubMed Web of Science ®Google Scholar
• Silverberg JI, Gelfand JM, Margolis DJ, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121(3):340–347. doi:10.1016/j.anai.2018.07.006
   PubMed Web of Science ®Google Scholar
• Korman NJ, Zhao Y, Pike J, Roberts J. Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA. Clin Exp Dermatol. 2016;41(5):514–521. doi:10.1111/ced.12841
   PubMed Web of Science ®Google Scholar
• Kirby JS, Butt M, Esmann S, Jemec GBE. Association of resilience with depression and health-related quality of life for patients with hidradenitis suppurativa. JAMA Dermatol. 2017;153(12):1263–1269. doi:10.1001/jamadermatol.2017.3596
   PubMed Web of Science ®Google Scholar
• Sun Q, Ren I, Zaki T, Maciejewski K, Choate K. Ichthyosis affects mental health in adults and children: a cross-sectional study. J Am Acad Dermatol. 2020;83(3):951–954. doi:10.1016/j.jaad.2020.01.052
   PubMed Web of Science ®Google Scholar
• Tan J, Beissert S, Cook-Bolden F, et al. Impact of facial atrophic acne scars on quality of life: a multi-country population-based survey. Am J Clin Dermatol. 2022;23(1):115–123. doi:10.1007/s40257-021-00628-1
   PubMed Web of Science ®Google Scholar
• Finlay AY, Salek MS, Abeni D, et al. Why quality of life measurement is important in dermatology clinical practice: an expert-based opinion statement by the EADV Task Force on Quality of Life. J Eur Acad Dermatol Venereol. 2017;31(3):424–431. doi:10.1111/jdv.13985
   PubMed Web of Science ®Google Scholar
• Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176(2):431–438. doi:10.1111/bjd.15122
   PubMed Web of Science ®Google Scholar
• van der Linden MM, van Rappard DC, Daams JG, Sprangers MA, Spuls PI, Korte J. and de Korte J. Health-related quality of life in patients with cutaneous rosacea: a systematic review. Acta Derm Venereol. 2015;95(4):395–400. doi:10.2340/00015555-1976
   PubMed Web of Science ®Google Scholar
• Holmes AD, Spoendlin J, Chien AL, Baldwin H, Chang ALS. Evidence-based update on rosacea comorbidities and their common physiologic pathways. J Am Acad Dermatol. 2018;78(1):156–166. doi:10.1016/j.jaad.2017.07.055
   PubMed Web of Science ®Google Scholar
• Incel Uysal P, Akdogan N, Hayran Y, Oktem A, Yalcin B. Rosacea associated with increased risk of generalized anxiety disorder: a case-control study of prevalence and risk of anxiety in patients with rosacea. An Bras Dermatol. 2019;94(6):704–709. doi:10.1016/j.abd.2019.03.002
   PubMed Web of Science ®Google Scholar
• Spoendlin J, Bichsel F, Voegel JJ, Jick SS, Meier CR. The association between psychiatric diseases, psychotropic drugs and the risk of incident rosacea. Br J Dermatol. 2014;170(4):878–883. doi:10.1111/bjd.12734
   PubMed Web of Science ®Google Scholar
• Hung CT, Chiang CP, Chung CH, Tsao CH, Chien WC, Wang WM. Risk of psychiatric disorders in rosacea: a nationwide, population-based, cohort study in Taiwan. J Dermatol. 2019;46(2):110–116. doi:10.1111/1346-8138.14705
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK, Chen SJ, Johnson AM. Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey--Outpatient Department data collected by the U.S. National Center for Health Statistics from 1995 to 2002. Br J Dermatol. 2005;153(6):1176–1181. doi:10.1111/j.1365-2133.2005.06895.x
   PubMed Web of Science ®Google Scholar
• Böhm D, Schwanitz P, Stock Gissendanner S, Schmid-Ott G, Schulz W. Symptom severity and psychological sequelae in rosacea: results of a survey. Psychol Health Med. 2014;19(5):586–591. doi:10.1080/13548506.2013.841968
   PubMed Web of Science ®Google Scholar
• Chen M, Deng Z, Huang Y, Li J. Prevalence and risk factors of anxiety and depression in rosacea patients: a cross-sectional study in China. Front Psychiatry. 2021;12:659171. doi:10.3389/fpsyt.2021.659171
   PubMed Web of Science ®Google Scholar
• Arck P, Handjiski B, Hagen E, et al. Is there a ‘gut-brain-skin axis’? Exp Dermatol. 2010;19(5):401–405. doi:10.1111/j.1600-0625.2009.01060.x
   PubMed Web of Science ®Google Scholar
• Koopman M. and El Aidy S. Depressed gut? The microbiota-diet-inflammation trialogue in depression. Curr Opin Psychiatry. 2017;30(5):369–377. doi:10.1097/YCO.0000000000000350
   PubMed Web of Science ®Google Scholar
• Buhl T, Sulk M, Nowak P, et al. Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1/Th17 pathways. J Invest Dermatol. 2015;135(9):2198–2208. doi:10.1038/jid.2015.141
   PubMed Web of Science ®Google Scholar
• Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(3):664–675. doi:10.1016/j.pnpbp.2010.06.014
   PubMed Web of Science ®Google Scholar
• Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107(2):234–256. doi:10.1016/j.neuron.2020.06.002
   PubMed Web of Science ®Google Scholar
• Amir Ali A, Vender R, Vender R. The role of IL-17 in papulopustular rosacea and future directions. J Cutan Med Surg. 2019;23(6):635–641. doi:10.1177/1203475419867611
   PubMed Web of Science ®Google Scholar
• Kini SP, Nicholson K, DeLong LK, et al. A pilot study in discrepancies in quality of life among three cutaneous types of rosacea. J Am Acad Dermatol. 2010;62(6):1069–1071. doi:10.1016/j.jaad.2009.08.020
   PubMed Web of Science ®Google Scholar
• Su D, Drummond PD. Blushing propensity and psychological distress in people with rosacea. Clin Psychol Psychother. 2012;19(6):488–495. doi:10.1002/cpp.763
   PubMed Web of Science ®Google Scholar